(Q43590303)

25 November 2017

title

Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer (English)

1 reference

25 November 2017

7

1 reference

25 November 2017

6

Postmus PE

1 reference

25 November 2017

Dingemans AC

1

1 reference

25 November 2017

van Ark-Otte J

2

1 reference

25 November 2017

Span S

3

1 reference

25 November 2017

Scagliotti GV

4

1 reference

25 November 2017

van der Valk P

5

1 reference

25 November 2017

publication date

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

32

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

117-128

1 reference

New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Determinants of Response to the DNA Topoisomerase II Inhibitors Doxorubicin and Etoposide in Human Lung Cancer Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Reduced topoisomerase II activity in multidrug-resistant human non-small cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Genistein resistance in human leukaemic CCRF-CEM cells: Selection of a diploid cell line with reduced DNA topoisomerase II β isoform

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

MDR1 gene expression in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Immunohistochemically detected p53 and P-glycoprotein predict the response to chemotherapy in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170- and 180-kDa isozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Analysis of M phase-specific phosphorylation of DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

A simple method to attach a universal 50-bp GC-clamp to PCR fragments used for mutation analysis by DGGE

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

[31] Detection and localization of single base changes by denaturing gradient gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Comparison of DNA topoisomerase IIα expression in small cell and nonsmall cell carcinoma of the lung: In search of a mechanism of chemotherapeutic response

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Clinical resistance to topoisomerase-targeted drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

DNA topoisomerase II mutations and resistance to anti-tumor drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900224-5

7 January 2021

10.1016/S0169-5002(00)00224-5

Identifiers

DOI

1 reference

25 November 2017

1 reference